Dimensional Fund Advisors
RXII

Dimensional Fund Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Dimensional Fund Advisors’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,913
Closed -$3K – 3532
2014
Q4 		$3K Hold
1,913
– – ﹤0.01% 3500
2014
Q3 		$4K Hold
1,913
– – ﹤0.01% 3523
2014
Q2 		$6K Hold
1,913
– – ﹤0.01% 3557
2014
Q1 		$5K Hold
1,913
– – ﹤0.01% 3573
2013
Q4 		$9K Hold
1,913
– – ﹤0.01% 3505
2013
Q3 		$4K Sell
1,913
-154
-7% -$322 ﹤0.01% 3553
2013
Q2 		$5K Buy
+2,067
New +$5K ﹤0.01% 3553

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Dimensional Fund Advisors's RXII Position: Q1 2015 in Review

Dimensional Fund Advisors sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2015, closing a stake of 1,913 shares — an estimated $3K sold.

Dimensional Fund Advisors first reported a position in RXII in Q2 2013 and held it in 7 quarters. The position peaked at $9K in Q4 2013. 87 funds tracked by Wall St. Rank hold RXII as of Q1 2015.

  • Dimensional Fund Advisors reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,913 GALENA BIOPHARMA INC COM shares in Q1 2015, an estimated $3K.
  • Dimensional Fund Advisors first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 7 quarters.
  • Dimensional Fund Advisors's GALENA BIOPHARMA INC COM position peaked at $9K in Q4 2013.
  • 87 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2015.

Based on Dimensional Fund Advisors's 13F filing for Q1 2015, filed 14 May 2015.